Cost-effectiveness of folic acid therapy for primary prevention of stroke in patients with hypertension

BACKGROUND: For hypertensive patients without a history of stroke or myocardial infarction (MI), the China Stroke Primary Prevention Trial (CSPPT) demonstrated that treatment with enalapril-folic acid reduced the risk of primary stroke compared with enalapril alone. Whether folic acid therapy is an...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Tiantian, Liang, Zhuoru, Lin, Tengfei, Cohen, David J., Arrieta, Alejandro, Wang, Xiaobin, Qin, Xianhui, Wang, Binyan, Huo, Yong, Liu, Gordon G., Jiang, Jie, Zhang, Zugui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594871/
https://www.ncbi.nlm.nih.gov/pubmed/36280851
http://dx.doi.org/10.1186/s12916-022-02601-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594871/
https://www.ncbi.nlm.nih.gov/pubmed/36280851
http://dx.doi.org/10.1186/s12916-022-02601-z

Ejemplares similares